Sagimet Biosciences Inc. (SGMT) stock
SGMTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$10.93−0.48 (-4.21%)
Close on Nov 12, 2026Market cap $679.39MP/E –Yield –
Sagimet Biosciences operating margin
Operating margin is operating income as a percentage of revenue.
Sagimet Biosciences's operating margin for the twelve months ending Dec 31, 2023 was -1537.0%. For fiscal 2023 it was -1537.0%.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | -1537.0% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2023 | Sep 30, 2023 | -372.6% | – |
See a number that looks wrong?